Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT06425276
What this trial is testing

Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation

Who this might be right for
Multiple Myeloma
CASI Pharmaceuticals (China) Co., Ltd. 67
Post-approval studies (Phase 4)UnknownNCT04738955
What this trial is testing

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

Who this might be right for
Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease
Shandong Provincial Hospital 230
Not applicableLooking for participantsNCT06537726
What this trial is testing

Breath Analysis for the Detection of Invasive Fungal Infections

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Lymphoblastic+4 more
University of Zurich 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT02577926
What this trial is testing

The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia

Who this might be right for
Polycythemia Vera (PV)Essential Thrombocythemia (ET)
RWTH Aachen University 207
Large-scale testing (Phase 3)UnknownNCT03256071
What this trial is testing

Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Hematopoietic Stem Cell TransplantationConditioning
The First Affiliated Hospital of Soochow University 90
Testing effectiveness (Phase 2)Study completedNCT01236144
What this trial is testing

A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome.

Who this might be right for
Acute Myeloid LeukaemiaHigh Risk Myelodysplastic Syndrome
Cardiff University 113
Testing effectiveness (Phase 2)Study completedNCT00060255
What this trial is testing

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerLeukemiaLymphoma+4 more
Roswell Park Cancer Institute 451
Testing effectiveness (Phase 2)Study completedNCT03207555
What this trial is testing

Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Malignant Neoplasms Stated as Primary Lymphoid HaematopoieticChronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Ended earlyNCT00374296
What this trial is testing

MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease

Who this might be right for
Myelogenous Leukemia, AcuteMyelodysplastic Syndromes
Mirati Therapeutics Inc. 35
Large-scale testing (Phase 3)Study completedNCT03301220
What this trial is testing

Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Janssen Research & Development, LLC 390
Large-scale testing (Phase 3)Study completedNCT02301156
What this trial is testing

Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
TG Therapeutics, Inc. 126
Testing effectiveness (Phase 2)Study completedNCT00007995
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Herbert Irving Comprehensive Cancer Center 75
Testing effectiveness (Phase 2)UnknownNCT04541277
What this trial is testing

Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia, in Relapsed or RefractoryAcute Myeloid Leukemia, Elderly, UnfitAcute Myeloid Leukemia With Positive Minimal Residual Disease
Chinese PLA General Hospital 55
Testing effectiveness (Phase 2)Study completedNCT00339196
What this trial is testing

5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS

Who this might be right for
Acute Myelogenous Leukaemia (AML)Myelodysplastic Syndrome (MDS)
Assistance Publique - Hôpitaux de Paris 25
Testing effectiveness (Phase 2)Study completedNCT00482261
What this trial is testing

Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

Who this might be right for
Multiple Myeloma
Peter MacCallum Cancer Centre, Australia 150
Large-scale testing (Phase 3)Active Not RecruitingNCT01208662
What this trial is testing

Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65

Who this might be right for
Multiple Myeloma
Paul Richardson, MD 729
Testing effectiveness (Phase 2)Study completedNCT00510926
What this trial is testing

Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Myeloid Leukemia, Chronic, Chronic-Phase
University of Bologna 80
Large-scale testing (Phase 3)Study completedNCT01305655
What this trial is testing

Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)
Nordic Society for Pediatric Hematology and Oncology 47
Early research (Phase 1)WithdrawnNCT04361058
What this trial is testing

Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic SyndromesMyelodysplastic Syndrome Acute Myeloid Leukemia
SCRI Development Innovations, LLC
Testing effectiveness (Phase 2)Ended earlyNCT01018069
What this trial is testing

AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen

Who this might be right for
Leukemia
Aegera Therapeutics 60
Next Page